Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
Ivan Budnik, Postdoctoral Research Scholar at The University of Iowa, shared on LinkedIn:
”I’m delighted to share that I’ve been awarded a two-year American Heart Association Postdoctoral Fellowship (2026–2027)!
Project: Metabolic reprogramming to enhance venous thrombus resolution and mitigate fibrotic vein wall injury.
I’m deeply thankful to my mentor, Dr. Anil Chauhan, for the opportunity to pursue this project and for his guidance along the way; to my lab members for an outstanding scientific environment; and to the leaders in the field who generously provided letters of support.
Thank you to the American Heart Association and the reviewers for valuing this work, which aims to improve long-term outcomes after deep vein thrombosis.”
More winner stories featured in Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis